+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

3D Printed Drugs Market Research Report by Technology, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 4857884
  • Report
  • January 2021
  • Region: Global
  • 184 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
The Global 3D Printed Drugs Market to Grow USD 392.11 Million by 2025, at a CAGR of 5.42%

FEATURED COMPANIES

  • 3D Systems Corporation
  • Biomedical Modeling Inc.
  • General Electric Company
  • Nanalyze
  • Prodways Group SA
  • SLM Solutions Group AG
The Global 3D Printed Drugs Market to Grow USD 392.11 Million by 2025, at a CAGR of 5.42%



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global 3D Printed Drugs Market is expected to grow from USD 301.03 Million in 2020 to USD 392.11 Million by the end of 2025.
2. The Global 3D Printed Drugs Market is expected to grow from EUR 263.95 Million in 2020 to EUR 343.81 Million by the end of 2025.
3. The Global 3D Printed Drugs Market is expected to grow from GBP 234.65 Million in 2020 to GBP 305.64 Million by the end of 2025.
4. The Global 3D Printed Drugs Market is expected to grow from JPY 32,128.57 Million in 2020 to JPY 41,848.28 Million by the end of 2025.
5. The Global 3D Printed Drugs Market is expected to grow from AUD 437.14 Million in 2020 to AUD 569.39 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the 3D Printed Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the 3D Printed Drugs Market is examined across Direct-Write, Fused Deposition Modelling, Inkjet Printing, Powder Bed Printing, Stereolithography, and Zip Dose.
  • Based on Application, the 3D Printed Drugs Market is examined across Dental, Hearing & Audibility Aid, Medical Implants, Neurology, and Orthopedic.
  • Based on End User, the 3D Printed Drugs Market is examined across Clinics & Hospitals and Research Laboratories.
  • Based on Geography, the 3D Printed Drugs Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global 3D Printed Drugs Market including 3D Systems Corporation, Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, BioDuro, LLC, Biomedical Modeling Inc., EnvisionTEC GmbH, FabRx Ltd., General Electric Company, Materialise NV, Merck KGaA, Nanalyze, Organovo Holdings, Inc., Pharma Excipients International AG, PreScouter, Inc., Prodways Group SA, Renishaw PLC, Siemens AG, SLM Solutions Group AG, Stratasys Ltd., Yissum, and Zortrax.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. the ongoing research amplifies the research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the 3D Printed Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global 3D Printed Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global 3D Printed Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global 3D Printed Drugs Market?
4. What is the competitive strategic window for opportunities in the Global 3D Printed Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global 3D Printed Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global 3D Printed Drugs Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3D Systems Corporation
  • Biomedical Modeling Inc.
  • General Electric Company
  • Nanalyze
  • Prodways Group SA
  • SLM Solutions Group AG
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. Application Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in demand for instantaneous soluble drugs
5.1.1.2. Increasing usage of 3D printing technique in the medical & healthcare industries
5.1.1.3. Growing adoption of personalized drugs, and production of the combination medicine
5.1.1.4. Increasing adoption of 3D printing technology
5.1.2. Restraints
5.1.2.1. Antagonistic effects related to these drugs
5.1.2.2. Usage of 3D printing to develop illegal drugs
5.1.3. Opportunities
5.1.3.1. Constant technological developments in 3D printing technique
5.1.3.2. Growth potential in developing countries with the introduction of 3D printed drugs
5.1.3.3. Rise in health care investment in emerging countries
5.1.4. Challenges
5.1.4.1. Lack of government regulations for 3D printed products
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global 3D Printed Drugs Market, By Technology
6.1. Introduction
6.2. Direct-Write
6.3. Fused Deposition Modelling
6.4. Inkjet Printing
6.5. Powder Bed Printing
6.6. Stereolithography
6.7. Zip Dose

7. Global 3D Printed Drugs Market, By Application
7.1. Introduction
7.2. Dental
7.3. Hearing & Audibility Aid
7.4. Medical Implants
7.5. Neurology
7.6. Orthopedic

8. Global 3D Printed Drugs Market, By End User
8.1. Introduction
8.2. Clinics & Hospitals
8.3. Research Laboratories

9. Americas 3D Printed Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific 3D Printed Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa 3D Printed Drugs Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 3D Systems Corporation
13.2. Anatomics Pty Ltd
13.3. Aprecia Pharmaceuticals, LLC
13.4. BioDuro, LLC
13.5. Biomedical Modeling Inc.
13.6. EnvisionTEC GmbH
13.7. FabRx Ltd.
13.8. General Electric Company
13.9. Materialise NV
13.10. Merck KGaA
13.11. Nanalyze
13.12. Organovo Holdings, Inc.
13.13. Pharma Excipients International AG
13.14. PreScouter, Inc.
13.15. Prodways Group SA
13.16. Renishaw PLC
13.17. Siemens AG
13.18. SLM Solutions Group AG
13.19. Stratasys Ltd.
13.20. Yissum
13.21. Zortrax

14. Appendix
14.1. Discussion Guide

List of Figures
Figure 1. Global 3D Printed Drugs Market: Research Process
Figure 2. Global 3D Printed Drugs Market: Research Execution
Figure 3. Global 3D Printed Drugs Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global 3D Printed Drugs Market Size, by Technology, 2020 (USD Million)
Figure 5. Global 3D Printed Drugs Market Size, by Application, 2020 (USD Million)
Figure 6. Global 3D Printed Drugs Market Size, by End-user, 2020 (USD Million)
Figure 7. Global 3D Printed Drugs Market Size, by Geography, 2020 (USD Million)
Figure 8. Global 3D Printed Drugs Market Size, 2018-2025 (USD Million)
Figure 9. Global 3D Printed Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 10. Global 3D Printed Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 11. Competitive Strategic Window for Global 3D Printed Drugs Market Size, by Geography, 2025
Figure 12. Global 3D Printed Drugs Market: Market Dynamics
Figure 13. Global 3D Printed Drugs Market: Porters Five Forces Analysis
Figure 14. Global 3D Printed Drugs Market Size, by Technology, 2020 Vs 2025 (%)
Figure 15. Global 3D Printed Drugs Market Size, by Technology, 2020 Vs 2025 (USD Million)
Figure 16. Competitive Strategic Window for Global 3D Printed Drugs Market Size, by Technology, 2025
Figure 17. Global 3D Printed Drugs Market Size, by Direct-Write, 2020 Vs 2025 (USD Million)
Figure 18. Global 3D Printed Drugs Market Size, by Fused Deposition Modelling, 2020 Vs 2025 (USD Million)
Figure 19. Global 3D Printed Drugs Market Size, by Inkjet Printing, 2020 Vs 2025 (USD Million)
Figure 20. Global 3D Printed Drugs Market Size, by Powder Bed Printing, 2020 Vs 2025 (USD Million)
Figure 21. Global 3D Printed Drugs Market Size, by Stereolithography, 2020 Vs 2025 (USD Million)
Figure 22. Global 3D Printed Drugs Market Size, by Zip Dose, 2020 Vs 2025 (USD Million)
Figure 23. Global 3D Printed Drugs Market Size, by Application, 2020 Vs 2025 (%)
Figure 24. Global 3D Printed Drugs Market Size, by Application, 2020 Vs 2025 (USD Million)
Figure 25. Competitive Strategic Window for Global 3D Printed Drugs Market Size, by Application, 2025
Figure 26. Global 3D Printed Drugs Market Size, by Dental, 2020 Vs 2025 (USD Million)
Figure 27. Global 3D Printed Drugs Market Size, by Hearing & Audibility Aid, 2020 Vs 2025 (USD Million)
Figure 28. Global 3D Printed Drugs Market Size, by Medical Implants, 2020 Vs 2025 (USD Million)
Figure 29. Global 3D Printed Drugs Market Size, by Neurology, 2020 Vs 2025 (USD Million)
Figure 30. Global 3D Printed Drugs Market Size, by Orthopedic, 2020 Vs 2025 (USD Million)
Figure 31. Global 3D Printed Drugs Market Size, by End-user, 2020 Vs 2025 (%)
Figure 32. Global 3D Printed Drugs Market Size, by End-user, 2020 Vs 2025 (USD Million)
Figure 33. Competitive Strategic Window for Global 3D Printed Drugs Market Size, by End-user, 2025
Figure 34. Global 3D Printed Drugs Market Size, by Clinics & Hospitals, 2020 Vs 2025 (USD Million)
Figure 35. Global 3D Printed Drugs Market Size, by Research Laboratories, 2020 Vs 2025 (USD Million)
Figure 36. Americas 3D Printed Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 37. Americas 3D Printed Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 38. Competitive Strategic Window for Americas 3D Printed Drugs Market Size, by Geography, 2025
Figure 39. Argentina 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 40. Brazil 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 41. Canada 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 42. Mexico 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 43. United States 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 44. Asia-Pacific 3D Printed Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 45. Asia-Pacific 3D Printed Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 46. Competitive Strategic Window for Asia-Pacific 3D Printed Drugs Market Size, by Geography, 2025
Figure 47. Australia 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 48. China 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 49. India 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 50. Indonesia 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. Japan 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. Malaysia 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. Philippines 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 54. South Korea 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 55. Thailand 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 56. Europe, Middle East & Africa 3D Printed Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 57. Europe, Middle East & Africa 3D Printed Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 58. Competitive Strategic Window for Europe, Middle East & Africa 3D Printed Drugs Market Size, by Geography, 2025
Figure 59. France 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 60. Germany 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 61. Italy 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 62. Netherlands 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 63. Qatar 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 64. Russia 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 65. Saudi Arabia 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 66. South Africa 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 67. Spain 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 68. United Arab Emirates 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 69. United Kingdom 3D Printed Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 70. Global 3D Printed Drugs Market: FPNV Positioning Matrix
Figure 71. Global 3D Printed Drugs Market: Market Share Analysis
Figure 72. Global 3D Printed Drugs Market: Competitor SWOT Analysis
Figure 73. Competitive Scenario Analysis in Global 3D Printed Drugs Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global 3D Printed Drugs Market Size, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 3. Global 3D Printed Drugs Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 4. Global 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 5. Global 3D Printed Drugs Market Size, by Direct-Write, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 6. Global 3D Printed Drugs Market Size, by Fused Deposition Modelling, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 7. Global 3D Printed Drugs Market Size, by Inkjet Printing, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 8. Global 3D Printed Drugs Market Size, by Powder Bed Printing, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 9. Global 3D Printed Drugs Market Size, by Stereolithography, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 10. Global 3D Printed Drugs Market Size, by Zip Dose, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 11. Global 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 12. Global 3D Printed Drugs Market Size, by Dental, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 13. Global 3D Printed Drugs Market Size, by Hearing & Audibility Aid, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 14. Global 3D Printed Drugs Market Size, by Medical Implants, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 15. Global 3D Printed Drugs Market Size, by Neurology, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 16. Global 3D Printed Drugs Market Size, by Orthopedic, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 17. Global 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 18. Global 3D Printed Drugs Market Size, by Clinics & Hospitals, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 19. Global 3D Printed Drugs Market Size, by Research Laboratories, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 20. Americas 3D Printed Drugs Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 21. Americas 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 22. Americas 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 23. Americas 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 24. Argentina 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 25. Argentina 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 26. Argentina 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 27. Brazil 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 28. Brazil 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 29. Brazil 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 30. Canada 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 31. Canada 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 32. Canada 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 33. Mexico 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 34. Mexico 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 35. Mexico 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 36. United States 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 37. United States 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 38. United States 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 39. Asia-Pacific 3D Printed Drugs Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 40. Asia-Pacific 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 41. Asia-Pacific 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 42. Asia-Pacific 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 43. Australia 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 44. Australia 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 45. Australia 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 46. China 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 47. China 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 48. China 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 49. India 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 50. India 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 51. India 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 52. Indonesia 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 53. Indonesia 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 54. Indonesia 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 55. Japan 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 56. Japan 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 57. Japan 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 58. Malaysia 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 59. Malaysia 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 60. Malaysia 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 61. Philippines 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 62. Philippines 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 63. Philippines 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 64. South Korea 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 65. South Korea 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 66. South Korea 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 67. Thailand 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 68. Thailand 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 69. Thailand 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 70. Europe, Middle East & Africa 3D Printed Drugs Market Size, by Geography, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 71. Europe, Middle East & Africa 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 72. Europe, Middle East & Africa 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 73. Europe, Middle East & Africa 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 74. France 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 75. France 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 76. France 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 77. Germany 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 78. Germany 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 79. Germany 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 80. Italy 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 81. Italy 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 82. Italy 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 83. Netherlands 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 84. Netherlands 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 85. Netherlands 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 86. Qatar 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 87. Qatar 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 88. Qatar 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 89. Russia 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 90. Russia 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 91. Russia 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 92. Saudi Arabia 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 93. Saudi Arabia 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 94. Saudi Arabia 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 95. South Africa 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 96. South Africa 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 97. South Africa 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 98. Spain 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 99. Spain 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 100. Spain 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 101. United Arab Emirates 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 102. United Arab Emirates 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 103. United Arab Emirates 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 104. United Kingdom 3D Printed Drugs Market Size, by Technology, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 105. United Kingdom 3D Printed Drugs Market Size, by Application, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 106. United Kingdom 3D Printed Drugs Market Size, by End-user, 2018-2025 (Usd/Eur/Gbp/Jpy/Aud Million)
Table 107. Global 3D Printed Drugs Market: Scores
Table 108. Global 3D Printed Drugs Market: Business Strategy
Table 109. Global 3D Printed Drugs Market: Product Satisfaction
Table 110. Global 3D Printed Drugs Market: Ranking
Table 111. Global 3D Printed Drugs Market: Merger & Acquisition
Table 112. Global 3D Printed Drugs Market: Agreement, Collaboration, & Partnership
Table 113. Global 3D Printed Drugs Market: New Product Launch & Enhancement
Table 114. Global 3D Printed Drugs Market: Investment & Funding
Table 115. Global 3D Printed Drugs Market: Award, Recognition, & Expansion
Note: Product cover images may vary from those shown

Loading
LOADING...

  • 3D Systems Corporation
  • Anatomics Pty Ltd
  • Aprecia Pharmaceuticals, LLC
  • BioDuro, LLC
  • Biomedical Modeling Inc.
  • EnvisionTEC GmbH
  • FabRx Ltd.
  • General Electric Company
  • Materialise NV
  • Merck KGaA
  • Nanalyze
  • Organovo Holdings, Inc.
  • Pharma Excipients International AG
  • PreScouter, Inc.
  • Prodways Group SA
  • Renishaw PLC
  • Siemens AG
  • SLM Solutions Group AG
  • Stratasys Ltd.
  • Yissum
  • Zortrax
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll